Incretin Agonist 22.66mg — Verification Report

From Ion Peptide · Lot ION1S20-04172026 · Tested April 2026

← Back to Ion Peptide

VialTalk

Verification report

Incretin Agonist 22.66mg

Ion Peptide

Score

107

Grade

A++

Superlative

Lot ION1S20-04172026

Tested April 2026

Report ID

58b94387

Test

Method

Result

Status

PurityFull credit

HPLC

99.96%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentFull credit

Gravimetric vs label claim

22.66 mg labeled · 22.66 mg tested

Full credit

EndotoxinFull credit

USP <85> compendial

Screened

Full credit

Heavy metalsFull credit

USP <232>/<233> compendial

Screened

Full credit

SterilityPartial

PCR / DNA microarray

Screened

Partial

Batch conformityStrong

Three-to-four vial average

Assessed

Strong

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →